COVID-19 booster for young children gets provisional approval
Maureen Dettre and Dominic Giannini
The medicines’ regulator has given provisional approval to a Pfizer COVID-19 vaccine booster for children aged five to 11.
However, the Therapeutic Goods Administration (TGA) said on Wednesday that the federal government’s decision on the use of the vaccine as a booster in the age group would be informed by advice from the Australian Technical Advisory Group on Immunisation (ATAGI).
Loading...
AAP
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Health & education
Fetching latest articles